Growth Metrics

Sangamo Therapeutics (SGMO) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $355000.0.

  • Sangamo Therapeutics' Interest & Investment Income rose 142.86% to $355000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 11018.83%. This contributed to the annual value of $5.9 million for FY2024, which is 4720.77% down from last year.
  • Per Sangamo Therapeutics' latest filing, its Interest & Investment Income stood at $355000.0 for Q3 2025, which was up 142.86% from $386000.0 recorded in Q2 2025.
  • In the past 5 years, Sangamo Therapeutics' Interest & Investment Income registered a high of $4.6 million during Q4 2024, and its lowest value of $309000.0 during Q1 2025.
  • Its 5-year average for Interest & Investment Income is $1.7 million, with a median of $1.5 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Sangamo Therapeutics' Interest & Investment Income was 21126.01% (2024), while the steepest drop was 9004.27% (2024).
  • Over the past 5 years, Sangamo Therapeutics' Interest & Investment Income (Quarter) stood at $2.3 million in 2021, then surged by 57.45% to $3.7 million in 2022, then tumbled by 59.43% to $1.5 million in 2023, then surged by 211.26% to $4.6 million in 2024, then plummeted by 92.36% to $355000.0 in 2025.
  • Its Interest & Investment Income stands at $355000.0 for Q3 2025, versus $386000.0 for Q2 2025 and $309000.0 for Q1 2025.